Palmitoyl Tripeptide-5 (Syn-Coll)

Various (Topical Cosmetic)

Palmitoyl Tripeptide-5 (trade name Syn-Coll) is a synthetic lipopeptide consisting of a palmitic acid chain conjugated to the tripeptide sequence Lys-Val-Lys (KVK). It was designed to mimic the thrombospondin-1 (TSP-1) activation domain of transforming growth factor beta (TGF-β), a master cytokine that orchestrates extracellular matrix remodeling in skin. By engaging the TGF-β signaling cascade without requiring the full-length cytokine, palmitoyl tripeptide-5 stimulates type I and type III collagen production in human dermal fibroblasts, while the palmitoyl tail enhances membrane permeability and stratum corneum penetration. In manufacturer-sponsored in-vitro studies, palmitoyl tripeptide-5 increased collagen synthesis by approximately 119% relative to untreated controls at micromolar concentrations. A small clinical trial (n=60) comparing a 100-ppm formulation against a retinol reference showed measurable improvements in wrinkle depth and skin firmness over 84 days, though independent replication of these results remains limited. The peptide is well-tolerated topically and does not carry the irritation profile associated with retinoids, positioning it as a gentler collagen-stimulating alternative suitable for sensitive skin types. It is frequently combined with Matrixyl (palmitoyl pentapeptide-4) or GHK-Cu in multi-peptide anti-aging formulations to address both signal peptide and copper-dependent remodeling pathways simultaneously.